Background—Studies of the association between the plasma concentration of lipoprotein
(a)[Lp (a)] and coronary heart disease (CHD) have reported apparently conflicting findings …

Objectives: The purpose of this study was to assess the prognostic utility of lipoprotein (a)[Lp
(a)] in individuals with coronary artery disease (CAD). Background: Data regarding an …

Background Large-scale prospective data are needed to determine whether associations
between lipoprotein (a)(Lp [a]) and coronary heart disease (CHD) risk are independent of …

The association of an elevated level of lipoprotein (a)(Lp (a)) with the development of
coronary heart disease (CHD) remains controversial. Lp (a) was investigated as a CHD risk …

Although in vitro studies support a pathophysiologic role for lipoprotein (a)[Lp (a)] in the
development of atherosclerosis, and retrospective studies consistently report that there is a …

To prospectively assess the role of lipoprotein (a)(Lp (a)) as a risk factor for coronary heart
disease, the serum Lp (a) concentration was determined in 130 subjects without coronary …

It has been estimated that∼ 37% of the US population judged to be at high risk for
developing coronary artery disease (CAD), based on the National Cholesterol Education …

Aims As promising compounds to lower Lipoprotein (a)(Lp (a)) are emerging, the need for a
precise characterization and comparability of the Lp (a)-associated cardiovascular risk is …

Background: Increased plasma lipoprotein (a)[Lp (a)] concentrations have been reported to
be an independent risk factor for coronary heart disease (CHD) in some prospective studies …

Objective.—To assess prospectively the risk of myocardial infarction (Ml) associated with
elevated levels of lipoprotein (a)(Lp [a]). Design.—Nested case-control study using …